← Back to all trials
Recruiting
NCT07703917
TENS for Postpartum Uterine Pain During Breastfeeding
Conditions: Breast Feeding
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 124
Sponsor: Holy Family Hospital, Nazareth, Israel
Location: Holy Family Hospital Nazareth
Summary
This clinical study is designed to evaluate whether Transcutaneous Electrical Nerve Stimulation (TENS) is an effective, non-drug method to relieve postpartum uterine pain during breastfeeding in multiparous women (women who have given birth multiple times). Breastfeeding in the first 48 hours after delivery often triggers strong, painful uterine contractions due to the natural release of oxytocin. While standard care typically relies on pain-relief medications, this study investigates if TENS, a safe, low-cost device that sends gentle electrical impulses through small skin patches, can significantly reduce this pain and decrease the need for systemic medications. Participants will be randomly assigned to either receive standard postpartum pain medications or use a TENS device during two consecutive breastfeeding sessions. Researchers will measure and compare the peak pain levels between both groups using a standard 0 to 10 pain scale. The aim is examining whether TENS will significantly reduce postpartum uterine pain during breastfeeding and decrease medication use compared with standard care.
Eligibility Criteria
Inclusion Criteria:
* Maternal Age above 18
* Term delivery (37 weeks or more)
* Vaginal delivery within the past 48 hours.
* Multiparous women (2 or more previous births)
* Delivery of a singleton
* Have the well to breastfeed
Exclusion Criteria:
* Contraindication to TENS (pacemaker, epilepsy, active infection, uncontrolled hyper / hypotension.)
* Chronic analgesia use
* Severe complications requiring intervention (severe PPH) or intensive care
* Skin lesions, infections, or scars at proposed electrode sites
* Neonatal intensive care unit admission
Source: ClinicalTrials.gov (NCT07703917). StuddyBuddy aggregates publicly available trial information.